News, analysis, and explainers connected to Macro across the CryptoCompass archive.
Newest first
Bessent Turns Up the Heat on Senate Democrats US Treasury Secretary Scott Bessent is pushing hard for a Senate floor vote on the Digital Asset Market CLARITY Act, warning that further delays
Senator Cynthia Lummis (@SenLummis) says the Digital Asset Market Clarity Act, known as the CLARITY Act, is still in contention for a Senate floor vote before the August recess, despite a pac
Zcash co-founder Zooko Wilcox has pushed back against concerns over undisclosed $ZEC inflation, stating that the current supply stands at exactly 16,848,458 ZEC and is fully verifiable by any
Our latest AMA came at one of the most important moments in Vanar’s history. The community has seen the new narrative, the Base migration announcement, the upcoming VANRY swap process, and th
When markets get jumpy, traders swarm to hedge, speculate, and rebalance. That flurry of orders turns into contracts, tickets, and fees. For an exchange, that can be a very good week. Case in
US spot Bitcoin exchange-traded funds recorded their strongest daily inflows in more than three weeks on Thursday after attracting a combined $233.1 million despite weakness in the Bitcoin pr
Bitget has upgraded BGBTC, its yield-bearing Bitcoin(BTC) token, adding daily rewards and shifting cross-chain transfers to Chainlink infrastructure. BGBTC Upgrade Adds Daily Bitcoin Rewards
Crypto Tax Rules 2026: A Global Country-by-Country Guide A widely shared Cointelegraph post on crypto tax rates around the world sparked fresh debate this week about how differently countries
If you are required to file a German income tax return for 2025 and you are doing it yourself, the clock runs out tonight. Not tomorrow morning, not the first working day of August. The statu
Coinbase, Strategy and Robinhood, three of crypto’s biggest listed names, reported second-quarter earnings within hours of each other between Wednesday and Thursday, and two of them told the
Picture an earnings call where one question keeps looping: can two fast-growing immunology drugs really replace a mega-blockbuster that defined a decade of pharma profits? That’s the AbbVie s
Evernorth Holdings, an XRP-focused fund planning to list on Nasdaq, has publicly detailed its executive compensation, tying leadership rewards to ambitious growth milestones and market perfor
